Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single ascending dose Cat-PAD safety study in cat-allergic subjects
2007-002715-11Phase 2Completed
- Sponsor
- NIOX Group
- Start
- Jun 2007
- Modality
- Vaccines & Immunotherapeutics, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label trial of Cat-PAD in cat allergy, perennial rhinitis and asthma (2 arms), sponsored by NIOX Group. Primary endpoints: Primary efficacy endpoint, Safety and tolerability and 1 more. Started Jun 2007; status: completed.
02
Drugs
Cat-PAD
03
Conditions
cat allergyperennial rhinitisasthma
Beyond the preview
Go deeper on 2007-002715-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002715-11.